ISSUES IN THE PHARMACOLOGICAL TREATMENT OF ADOLESCENT SUBSTANCE-ABUSE

被引：7
作者：
KAMINER, Y
机构：
[1] Department of Psychiatry and Alcohol Research Center, University of Connecticut School of Medicine, Farmington, Connecticut
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 1995年 / 5卷 / 02期
关键词：
D O I：
10.1089/cap.1995.5.93
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Pharmacotherapy of substance-related disorders (SRD) in adolescents is a neglected therapeutic modality that has only recently shown some progress, primarily in the form of published single case studies and pilot studies. There has been no systemic research evaluating the efficacy and safety of any psychotropic medication in the treatment of adolescents with SRD. Pharmacotherapy for abuse and dependence on nicotine, alcohol, cocaine, and opioids is reviewed, with special emphasis on adolescents' needs and characteristics of their drug use. Marijuana, hallucinogens, inhalants, and polysubstance abuse are not discussed, due to the lack of empirical data on their pharmacotherapy. There is no reason to assume that detoxification protocols should be different in adolescents and adults. No single strategy appears likely to treat all adolescents with SRD, and it seems likely that the cumulative effect of several treatment modalities is better than a single pharmacological intervention. Adolescents give low priority to pharmacotherapy among their SRD treatments. ''Treatment dosage,'' as a summation of the effects of comprehensive treatment modalities based patient-treatment matching, may improve the public understanding of treatment programs.
引用
收藏
页码：93 / 106
页数：14
相关论文
共 84 条
[1]  
Alterman A.I., O'Brien C.P., McLellan A.T., Differential therapeutics for substance abuse, Clinical Textbook of Addictive Disorders., pp. 369-390, (1991)
[2]  
Ambrosini P.J., Bianchi M.D., Rabinovich H., Elia J., Antidepressant treatments in children and adolescents, J Am Acad Child Adolesc Psychiat, 32, pp. 1-6, (1993)
[3]  
Ambrosini P.J., Bianchi M.D., Rabinovich H., Metz C., Rabinovich H., Evaluating clinical response of open nortriptyline pharmacotherapy in adolescent major depression, J Child Adolesc Psychopharmacol, 4, pp. 233-244, (1994)
[4]  
American College of Physicians: Disulfiram treatment of alcoholism, Ann Intern Med, 111, pp. 943-945, (1989)
[5]  
American Medical Association, Council on Scientific Affairs: Aversion therapy. JAMA, 258, pp. 2562-2566, (1987)
[6]  
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (1987)
[7]  
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, (1994)
[8]  
Anderson J.C., Williams S., McGee R., Silva P.A., DSM-III disorders in preadolescent children, Arch Gen.Psychiat, 44, pp. 69-76, (1987)
[9]  
Babor T.P., DelBoca F.K., McLaney M.A., Jacobi B., Higgins-Biddle J., Hass W., Just say Y.E.S. Matching adolescents to appropriate interventions for alcohol and other drug-related problems, Alcohol World and Health Res, 15, pp. 77-86, (1991)
[10]  
Babor T.F., Hoffman M., DelBoca F.K., Hesselbrock V., Meyer R.E., DoUnsky Z.S., Rounsaville B., Types of alcoholics: II. Evidence for an empirically-derived typology based on indicators of vulnerability and severity, Arch Gen Psychiat, 49, pp. 599-608, (1992)
123456789